| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1053448872 |
| P356 | DOI | 10.1038/TPJ.2010.22 |
| P698 | PubMed publication ID | 20351753 |
| P2093 | author name string | C H Kim | |
| Y S Kim | |||
| I Kim | |||
| H C Lee | |||
| C W Ahn | |||
| S-H Jeong | |||
| B S Cha | |||
| E S Kang | |||
| J H Rim | |||
| S J Ko | |||
| Y S Yim | |||
| P2860 | cites work | Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells | Q24292494 |
| Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules | Q24301974 | ||
| In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion | Q24303979 | ||
| The International HapMap Project | Q27860695 | ||
| Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants | Q28249275 | ||
| A genome-wide association study identifies novel risk loci for type 2 diabetes | Q28287727 | ||
| Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion | Q28506358 | ||
| Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion | Q28564600 | ||
| Ca2+-dependent dephosphorylation of kinesin heavy chain on beta-granules in pancreatic beta-cells. Implications for regulated beta-granule transport and insulin exocytosis | Q28576907 | ||
| Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels | Q29547214 | ||
| Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years | Q31904809 | ||
| HNF4alpha and HNF1alpha dysfunction as a molecular rational for cyclosporine induced posttransplantation diabetes mellitus | Q33413749 | ||
| Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo | Q33947920 | ||
| Pharmacological agents that directly modulate insulin secretion | Q33964696 | ||
| Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management | Q34555444 | ||
| Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function | Q34567627 | ||
| Calcineurin/NFAT signaling in the beta-cell: From diabetes to new therapeutics | Q34689362 | ||
| New-onset diabetes after kidney transplantation: risk factors. | Q36665946 | ||
| New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection | Q37065465 | ||
| Genome-wide association study for type 2 diabetes: clinical applications | Q37412138 | ||
| Down syndrome candidate region 1 increases the stability of the IkappaBalpha protein: implications for its anti-inflammatory effects | Q40216264 | ||
| Glucose Sensitivity and Metabolism-Secretion Coupling Studied during Two-Year Continuous Culture in INS-1E Insulinoma Cells | Q42798453 | ||
| Rapamycin impairs metabolism-secretion coupling in rat pancreatic islets by suppressing carbohydrate metabolism | Q43265419 | ||
| beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus | Q43629277 | ||
| New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines | Q43977077 | ||
| Diabetes mellitus after kidney transplantation in the United States | Q44326129 | ||
| Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study | Q45281305 | ||
| New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression | Q46449548 | ||
| mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes | Q46823840 | ||
| The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events | Q46881097 | ||
| Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. | Q51476761 | ||
| A Polymorphism in the Zinc Transporter Gene SLC30A8 Confers Resistance Against Posttransplantation Diabetes Mellitus in Renal Allograft Recipients | Q57500079 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 191-198 | |
| P577 | publication date | 2010-03-30 | |
| P1433 | published in | The Pharmacogenomics Journal | Q10534704 |
| P1476 | title | A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion | |
| P478 | volume | 11 |
| Q36022057 | A Syntenic Cross Species Aneuploidy Genetic Screen Links RCAN1 Expression to β-Cell Mitochondrial Dysfunction in Type 2 Diabetes |
| Q35715829 | Association between SLC30A8 rs13266634 Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis |
| Q38245901 | Dorothy Hodgkin Lecture 2014. Understanding genes identified by genome-wide association studies for type 2 diabetes |
| Q35861895 | Effect of zinc supplementation on insulin secretion: interaction between zinc and SLC30A8 genotype in Old Order Amish |
| Q33671124 | Exploring the Association Between Demographics, SLC30A8 Genotype, and Human Islet Content of Zinc, Cadmium, Copper, Iron, Manganese and Nickel |
| Q33726555 | Expression and functional assessment of candidate type 2 diabetes susceptibility genes identify four new genes contributing to human insulin secretion |
| Q39224992 | Identification of novel HLA-A 0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8. |
| Q48169638 | Implications of impaired zinc homeostasis in diabetic cardiomyopathy and nephropathy. |
| Q51310702 | Lipid-tuned Zinc Transport Activity of Human ZnT8 Protein Correlates with Risk for Type-2 Diabetes. |
| Q37198275 | Molecular Genetic Regulation of Slc30a8/ZnT8 Reveals a Positive Association With Glucose Tolerance |
| Q37073892 | Over-expression of Slc30a8/ZnT8 selectively in the mouse α cell impairs glucagon release and responses to hypoglycemia |
| Q42209549 | Post-renal transplant diabetes mellitus in korean subjects: superimposition of transplant-related immunosuppressant factors on genetic and type 2 diabetic risk factors |
| Q38257329 | SLC30A8 mutations in type 2 diabetes |
| Q36065083 | The Zinc Transporter Slc30a8/ZnT8 Is Required in a Subpopulation of Pancreatic α-Cells for Hypoglycemia-induced Glucagon Secretion |
| Q28390590 | Zinc and zinc transporter regulation in pancreatic islets and the potential role of zinc in islet transplantation |
| Q26829276 | Zinc transporter 8 (ZnT8) and β cell function |
Search more.